Lichter Jay's Form 4 filing
Janux Therapeutics, Inc. (JANX) · filed Oct 18, 2024
- Accession no.
- 0001415889-24-025436
- Filed
- Oct 18, 2024, 6:51 PM ET
- Trade date
- Oct 16-18, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 25 non-derivative transactions and 8 derivative transactions. Open-market sales total $77.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lichter JayCIK 0001376355 | 10% Owner |
| Avalon Ventures XI, L.P.CIK 0001652901 | 10% Owner |
| Avalon BioVentures SPV I, L.P.CIK 0001844550 | 10% Owner |
| Avalon BioVentures I, LPCIK 0001873935 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2024 | Common Stock | SSaleDisposed | −60,179 | $49.69 | −$2,990,294.51 | 2,761,291 | Direct | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −11,657 | $49.69 | −$579,236.33 | 534,883 | Indirect | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −61,445 | $49.69 | −$3,053,202.05 | 2,819,366 | Indirect | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −29,474 | $50.61 | −$1,491,679.14 | 2,731,817 | Direct | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −5,710 | $50.61 | −$288,983.1 | 529,173 | Indirect | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −30,094 | $50.61 | −$1,523,057.34 | 2,789,272 | Indirect | |
| Oct 16, 2024 | Common Stock | MOption exerciseAcquired | +4,968 | $17.00 | +$84,456 | 11,855 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseAcquired | +2,070 | $10.73 | +$22,211.1 | 13,925 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseAcquired | +2,070 | $13.22 | +$27,365.4 | 15,995 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseAcquired | +1,407 | $39.80 | +$55,998.6 | 17,402 | Direct | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −10,957 | $50.80 | −$556,615.6 | 6,445 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseAcquired | +836 | $17.00 | +$14,212 | 7,281 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseAcquired | +348 | $10.73 | +$3,734.04 | 7,629 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseAcquired | +348 | $13.22 | +$4,600.56 | 7,977 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseAcquired | +237 | $39.80 | +$9,432.6 | 8,214 | Direct | |
| Oct 17, 2024 | Common Stock | SSaleDisposed | −1,843 | $50.02 | −$92,186.86 | 6,371 | Direct | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −102,732 | $50.30 | −$5,167,419.6 | 2,629,085 | Direct | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −19,900 | $50.30 | −$1,000,970 | 509,273 | Indirect | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −104,892 | $50.30 | −$5,276,067.6 | 2,684,380 | Indirect | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −15,462 | $51.18 | −$791,345.16 | 2,613,623 | Direct | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −2,995 | $51.18 | −$153,284.1 | 506,278 | Indirect | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −15,788 | $51.18 | −$808,029.84 | 2,668,592 | Indirect | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −541,824 | $44.75 | −$24,246,624 | 2,071,799 | Direct | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −104,957 | $44.75 | −$4,696,825.75 | 401,321 | Indirect | |
| Oct 18, 2024 | Common Stock | SSaleDisposed | −553,219 | $44.75 | −$24,756,550.25 | 2,115,373 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2024 | Common Stock | MOption exerciseDisposed | −4,968 | $0.00 | $0 | 22,776 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseDisposed | −2,070 | $0.00 | $0 | 9,490 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseDisposed | −2,070 | $0.00 | $0 | 9,490 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseDisposed | −1,407 | $0.00 | $0 | 6,309 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseDisposed | −836 | $0.00 | $0 | 21,940 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseDisposed | −348 | $0.00 | $0 | 9,142 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseDisposed | −348 | $0.00 | $0 | 9,142 | Direct | |
| Oct 17, 2024 | Common Stock | MOption exerciseDisposed | −237 | $0.00 | $0 | 6,072 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.